Baricitinib not linked to adverse cardiovascular outcomes in RA - Healio
Baricitinib not linked to adverse cardiovascular outcomes in RA Healio
Baricitinib demonstrated no association with major adverse cardiovascular or venous thromboembolic events among patients with rheumatoid arthritis, ...
Comments
Post a Comment